Future of Sales and Marketing beyond COVID - hybrid event in Vilnius: physical audience of 800 + 300 virtual. Digital marketing, location marketing. How to create MAGIC in new marketing campaigns. Future of Marketing Keynote Speaker

Chances of 2 people in 70 having same birthday? Managing Risk in Banking and Financial Services. Why the greatest risks are combinations of very unlikely events, which happen far more often than you expect. Keynote speaker on risk management

Compliance is Dead. How to build trust. Reputation of banks and financial services. Compliance Risks. Why 100% compliance with regulations, ESG requirements etc is often not enough to prevent reputational damage

Life's too short to do things you don't believe in! Why passionate belief in the true value of what you are selling or doing is the number one key to success. Secret of all leadership and marketing - keynote for 1100 people in Vilnius October 2021

Why you can't innovate on Zoom or Teams meetings - Innovation is almost impossible unless breathing same air, in same room

Why the key to rapid innovation is team diversity - survey global CEOs. Innovation keynote speaker

Future Manufacturing 5.0. Lessons from personal life for all manufacturers. Manufacturing Keynote

Future of Manufacturing: diagnostics; predictive analytics, little data and cybersecurity. Keynote

Manufacturing 5 0: The truth about robots, robotics and automation. Future of Manufacturing Keynote

Manufacturing 5.0 - why Manufacturing 4.0 not enough. Agility and Innovation: Manufacturing Keynote

Future of Manufacturing 5.0 - hyperconnected, sustainable factories and supply chains + human beings

80% of sales are won or lost in 3 seconds - Future of Marketing Keynote Speaker - Pardavimu formule

Swine Flu Mexico shutdown: update and comment

Futurist Keynote Speaker: Posts, Slides, Videos - Future Health Care and Pharma Keynote Speaker

Comment in early days of Mexico Swine Flu epidemic in 2009:

Research suggests that the virus causing Swine Flu (H1N1) may turn out to be quite similar to normal flu in mortality rates (1 in 1000).  This is based on a genetic analysis which shows that the virus has receptors which bind to the nose and upper airways, rather than to lung tissue.  This makes it more infectious but probably less dangerous for each person infected.  But these are early days.

Meanwhile, the entire country of Mexico has begun a five day shut down of non-essential government services, schools, cinemas, restaurants and many other businesses.  Rate of new suspected cases appeas to be slowing, but it is too early to tell if the virus is coming under control. Mexico is reporting around 300 confirmed cases and 12 confirmed deaths from Swine Flu plus possibility of another 160 or more deaths from the virus.

The US is buying 13 million extra courses of antiviral treatment and sending 400,000 to Mexico.

WHO will in future refer to Swine Flu virus as H1N1 to help reassure people that pork meat is safe to eat, and to emphasise that the H1N1 is spreading between humans.

WHO press release 1 May 2009 - less up to date than text above:  The situation continues to evolve rapidly. As of 06:00 GMT, 1 May 2009, 11 countries have officially reported 331 cases of influenza A(H1N1) infection. The United States Government has reported 109 laboratory confirmed human cases, including one death. Mexico has reported 156 confirmed human cases of infection, including nine deaths. The following countries have reported laboratory confirmed cases with no deaths - Austria (1), Canada (34), Germany (3), Israel (2), Netherlands (1), New Zealand (3), Spain (13), Switzerland (1) and the United Kingdom (8).


Related news items:
Newer news items:
Older news items:


Thanks for promoting with Facebook LIKE or Tweet. Really interested to read your views. Post below.

Join the Debate! What are your own views?


?

 

Search for your future



Our cookie policy

We use cookies for statistical purposes. To comply with the e-Privacy Directive we need to ask your consent to place these cookies on your computer.

Your use of this site indicates acceptance of these terms. I accept